Drug Trial Radar · NCT04711915
Fixed Order, Open-Label, Dose-Escalation Study of DMT in Humans
Last checked: Nov 20, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
10
Planned (sponsor's estimate)
Start
Mar 17, 2021
Primary completion
Jul 1, 2030
Study completion Dec 1, 2030
Sponsor
- Lead sponsor
- Yale UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jan 15, 2021
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Other
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 21 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The goal of this fixed order, open-label, dose-escalation study is to investigate the safety and efficacy of specific doses of dimethyltryptamine (DMT) in humans.
Conditions
- Major Depressive Disorder
- Depression
Interventions
0.1 mg/kg Dimethyltryptamine (DMT)Drug
0.1 mg/kg DMT
0.3 mg/kg Dimethyltryptamine (DMT)Drug
0.3 mg/kg DMT
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Blood PressureTime frame: -60 and -30 minutes before DMT administration; 0, +5, +10, +15, +20, +30, +45, +60, and +120 minutes after DMT administration
- Change in Heart RateTime frame: -60 and -30 minutes before DMT administration; 0, +5, +10, +15, +20, +30, +45, +60, and +120 minutes after DMT administration
- Change in Psychedelic EffectsTime frame: -60 minutes before DMT administration; 0, +30, and +60 minutes after DMT administration
- Change in AnxietyTime frame: -60 minutes before DMT administration; 0, +30, and +60 minutes after DMT administration
- Drug Reinforcing EffectsTime frame: +120 minutes after DMT administration
- Overall Tolerability assessed by the VASTime frame: +120 minutes after DMT administration
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Biological Studies Unit at the VA Connecticut Healthcare System, Yale School of Medicine
West Haven, Connecticut · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.